Not a good buy right now: trend is bearish (SMA_200 > SMA_20 > SMA_5) and price is below the pivot (0.944), with additional weakness pre/post market.
No Intellectia buy-type triggers today (AI Stock Picker and SwingMax both show no signal), removing the strongest “act now” justification for an impatient entry.
With no near-term news catalysts and weak/unclear fundamentals (revenue shown as 0, still negative earnings), the risk/reward does not favor an immediate buy.
Technical Analysis
Price: 0.93 vs pivot 0.944 → trading below pivot, near support zone.
RSI(6): 46.2 (neutral) → no oversold bounce signal.
MACD histogram: +0.000764 but “positively contracting” → bullish momentum is fading rather than accelerating.
Levels: Support S1 0.865 (then S2 0.817); Resistance R1 1.023 (then R2 1.071). A better technical buy would typically be either a strong reclaim above 0.944/1.023 or a confirmed bounce off 0.865 with momentum improving.
Recent tape: Regular -2.09%, pre -4.81%, post -3.53% → sellers still active outside regular hours.
Pattern-based projection (similar candlestick mapping) suggests potential upside: +1.56% next day, +3.4% next week, +9.96% next month.
MACD remains slightly positive (histogram above 0), implying downside momentum is not aggressively accelerating at the moment.
Neutral/Negative Catalysts
signals a downtrend.
Financial Performance
Latest quarter: 2025/Q2.
Revenue: reported as 0 (0.00% YoY) → top-line signal is weak/unclear based on provided snapshot.
Net income: -893,896 (improved YoY per snapshot) but still negative → company remains loss-making.
EPS: -0.24 (improved YoY per snapshot) but still negative.
Overall: the quarter shows improvement in losses, but fundamentals provided do not show healthy, scalable growth that would justify an impatient buy into a bearish chart.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating / price target change data was provided, so the current Wall Street stance cannot be validated from this dataset.
Practical takeaway from available inputs: without analyst upgrades/targets and without news catalysts, the bull case relies mostly on a technical bounce that is not yet confirmed.
Wall Street analysts forecast ALPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALPS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast ALPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALPS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
